VEGF-Induced Growth Cone Enhancement Is Diminished by Inhibiting Tyrosine-Residue 1214 of VEGFR-2

Publisher： Karger

E-ISSN： 1422-6421|196|3|195-205

ISSN： 1422-6405

Source： Cells Tissues Organs, Vol.196, Iss.3, 2012-03, pp. : 195-205

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exploring QSARs of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Tyrosine Kinase Inhibitors by MLR, PLS and PC-ANN

By  

Current Pharmaceutical Design, Vol. 19, Iss. 12, 2013-01 ,pp. : 2237-2244

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Pigment Epithelium-Derived Factor (PEDF) Augments Vascular Endothelial Growth Factor (VEGF)-Induced Recovery of Limb Perfusion after Ischemia in Klotho Mouse

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 7, 2010-08 ,pp. : 541-545

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors

By Steeghs Neeltje   Gelderblom Hans   Wessels Judith   Eskens Ferry   Bont Natasja   Nortier Johan   Guchelaar Henk-Jan  

Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. : 137-143

Springer Publishing Company

Access to resources Recommend Favorite

VEGF/VEGFR2 Signaling Regulates Germ Cell Proliferation in vitro and Promotes Mouse Testicular Regeneration in vivo

By  

Cells Tissues Organs, Vol. 201, Iss. 1, 2015-0 ,pp. : 1-13

Karger

Access to resources Recommend Favorite

Identification of VEGF receptor-2 tyrosine phosphorylation sites involved in VEGF-mediated endothelial platelet-activating factor synthesis

By Rechka Abdennebi   Neagoe Paul-Eduard   Gratton Jean-Philippe   Sirois Martin G.  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 10, 2010-10 ,pp. : 968-976

NRC Research Press

Access to resources Recommend Favorite